Baxter International Inc (BAX): Total Assets
$20.05B
As of 2025-12-31
$19.79B
As of 2026-06-30
-10.8%
3-year compound annual growth
0.0%
5-year compound annual growth
-0.4%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $20.05B | -22.2% | 2026-02-12, Balance as of period end |
| 2024-12-31 | $25.78B | -8.8% | 2026-02-12, Balance as of period end |
| 2023-12-31 | $28.28B | 0.0% | 2025-02-21, Balance as of period end |
| 2022-12-31 | $28.29B | -15.6% | 2024-02-08, Balance as of period end |
| 2021-12-31 | $33.52B | +67.4% | 2023-02-09, Balance as of period end |
| 2020-12-31 | $20.02B | +10.0% | 2022-02-23, Balance as of period end |
| 2019-12-31 | $18.19B | n/a | 2021-02-11, Balance as of period end |
| 2019-06-30 | $17.50B | n/a | 2020-03-17, Balance as of period end |
| 2019-03-31 | $16.24B | n/a | 2020-03-17, Balance as of period end |
| 2018-12-31 | $15.72B | n/a | 2020-03-17, Balance as of period end |
| 2018-09-30 | $16.80B | n/a | 2020-03-17, Balance as of period end |
| 2018-06-30 | $16.52B | n/a | 2020-03-17, Balance as of period end |
| 2018-03-31 | $16.84B | n/a | 2020-03-17, Balance as of period end |
| 2017-12-31 | $17.11B | +10.1% | 2019-02-21, Balance as of period end |
| 2016-12-31 | $15.55B | -25.8% | 2018-02-23, Balance as of period end |
| 2015-12-31 | $20.96B | -19.8% | 2017-02-23, Balance as of period end |
| 2014-12-31 | $26.14B | +3.6% | 2017-02-23, Balance as of period end |
| 2013-12-31 | $25.22B | +23.7% | 2016-02-26, Balance as of period end |
| 2012-12-31 | $20.39B | +6.9% | 2015-02-26, Balance as of period end |
| 2011-12-31 | $19.07B | +9.1% | 2014-02-21, Balance as of period end |
| 2010-12-31 | $17.49B | +0.8% | 2013-02-21, Balance as of period end |
| 2009-12-31 | $17.35B | +12.7% | 2012-02-23, Balance as of period end |
| 2008-12-31 | $15.40B | n/a | 2011-02-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Baxter International Inc (BAX) | 2025-12-31 | $20.05B | -22.2% |
| Solventum Corp (SOLV) | 2025-12-31 | $14.29B | -1.1% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $43.67B | +10.9% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $55.33B | -3.4% |
| ResMed Inc (RMD) | 2026-06-30 | $8.97B | +9.7% |
| 3M Co (MMM) | 2025-12-31 | $37.73B | -5.4% |
| Stryker Corp (SYK) | 2025-12-31 | $47.84B | +11.3% |
| Dexcom Inc (DXCM) | 2025-12-31 | $6.34B | -2.2% |
| Medline Inc. (MDLN) | 2025-12-31 | $38.48B | +7.0% |
Compare BAX, SOLV, BSX, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗